13F HOLDINGS REPORT
SILVERARC CAPITAL MANAGEMENT, LLC
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001420506-23-001985
Total Value
$329.8M
Positions
80
Other Managers
1
Confidential Omitted
No
Holdings (80)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPRD S&P Biotech ETF | 78464A870 | 300,000 | $21.9M | 6.64% |
| 2 | ImmunoGen Inc | 45253H101 | 1,307,435 | $20.7M | 6.29% |
| 3 | Morphic Holding Inc | 61775R105 | 590,829 | $13.5M | 4.10% |
| 4 | Merus NV | N5749R100 | 500,000 | $11.8M | 3.57% |
| 5 | Soleno Therapeutics Inc | SLNO | 370,000 | $10.9M | 3.31% |
| 6 | Intra-Cellular Therapies Inc | 46116X101 | 208,730 | $10.9M | 3.30% |
| 7 | Akero Therapeutics Inc | 00973Y108 | 200,000 | $10.1M | 3.07% |
| 8 | CymaBay Therapeutics Inc | 23257D103 | 590,000 | $8.8M | 2.67% |
| 9 | Mirati Therapeutics Inc | 60468T105 | 200,000 | $8.7M | 2.64% |
| 10 | Poseida Therapeutics Inc | 73730P108 | 3,567,985 | $8.5M | 2.57% |
| 11 | Krystal Biotech Inc | KRYS | 71,531 | $8.3M | 2.52% |
| 12 | Biogen Idec Inc | BIIB | 28,069 | $7.2M | 2.19% |
| 13 | Urogen Pharma Ltd | URGN | 508,883 | $7.1M | 2.16% |
| 14 | United Therapeutics Corp | UTHR | 31,424 | $7.1M | 2.15% |
| 15 | Praxis Precision Medicines Inc | PRAX | 4,117,920 | $7.0M | 2.14% |
| 16 | Oric Pharmaceuticals Inc | ORIC | 1,123,345 | $6.8M | 2.06% |
| 17 | Crinetics Pharmaceuticals Inc | CRNX | 220,000 | $6.5M | 1.98% |
| 18 | Mirati Therapeutics Inc | 60468T105 | 150,000 | $6.5M | 1.98% |
| 19 | Cogent Biosciences Inc | COGT | 651,372 | $6.4M | 1.93% |
| 20 | Mersana Therapeutics Inc | 59045L106 | 5,000,000 | $6.3M | 1.93% |
| 21 | Rhythm Pharmaceuticals Inc | RYTM | 260,537 | $6.0M | 1.81% |
| 22 | MacroGenics Inc | MGNX | 1,264,158 | $5.9M | 1.79% |
| 23 | BioCryst Pharmaceuticals Inc | BCRX | 791,671 | $5.6M | 1.70% |
| 24 | Novo Nordisk A/S | NONOF | 60,000 | $5.5M | 1.65% |
| 25 | Akero Therapeutics Inc | 00973Y108 | 106,600 | $5.4M | 1.63% |
| 26 | Veracyte Inc | VCYT | 239,571 | $5.3M | 1.62% |
| 27 | KalVista Pharmaceuticals Inc | KALV | 530,400 | $5.1M | 1.55% |
| 28 | Gossamer Bio Inc | GOSS | 6,130,268 | $5.1M | 1.55% |
| 29 | Olema Pharmaceuticals Inc | OLMA | 407,801 | $5.0M | 1.53% |
| 30 | Humana Inc | HUM | 10,000 | $4.9M | 1.48% |
| 31 | Vertex Pharmaceuticals Inc | VRTX | 13,765 | $4.8M | 1.45% |
| 32 | Gilead Sciences Inc | GILD | 62,789 | $4.7M | 1.43% |
| 33 | Pliant Therapeutics Inc | PLRX | 250,409 | $4.3M | 1.32% |
| 34 | Caribou Biosciences Inc | CRBU | 892,786 | $4.3M | 1.29% |
| 35 | ImmunoGen Inc | 45253H101 | 250,000 | $4.0M | 1.20% |
| 36 | Tela Bio Inc | TELA | 490,471 | $3.9M | 1.19% |
| 37 | Insmed Inc | INSM | 150,387 | $3.8M | 1.15% |
| 38 | Mirum Pharmaceuticals Inc | MIRM | 110,114 | $3.5M | 1.06% |
| 39 | CymaBay Therapeutics Inc | 23257D103 | 200,000 | $3.0M | 0.90% |
| 40 | Reviva Pharmaceuticals Holdings Inc | 76152G100 | 564,000 | $2.8M | 0.83% |
| 41 | Zura Bio Ltd | ZURA | 404,040 | $2.7M | 0.81% |
| 42 | Terns Pharmaceuticals Inc | TERN | 500,000 | $2.5M | 0.76% |
| 43 | Molecular Templates Inc | 608550208 | 354,608 | $2.2M | 0.68% |
| 44 | KalVista Pharmaceuticals Inc | KALV | 228,934 | $2.2M | 0.67% |
| 45 | Trevi Therapeutics Inc | TRVI | 927,415 | $2.0M | 0.61% |
| 46 | Kodiak Sciences Inc | KOD | 1,114,461 | $2.0M | 0.61% |
| 47 | Cerus Corp | CERS | 1,203,890 | $2.0M | 0.59% |
| 48 | Xenon Pharmaceuticals Inc | XENE | 53,996 | $1.8M | 0.56% |
| 49 | Evogene Ltd | EVGN | 3,100,000 | $1.8M | 0.55% |
| 50 | Intellia Therapeutics Inc | NTLA | 53,018 | $1.7M | 0.51% |
| 51 | Akero Therapeutics Inc | 00973Y108 | 31,336 | $1.6M | 0.48% |
| 52 | Aclaris Therapeutics Inc | ACRS | 199,000 | $1.4M | 0.41% |
| 53 | Aerovate Therapeutics Inc | 008064107 | 100,000 | $1.4M | 0.41% |
| 54 | Prothena Corporation PLC | PRTA | 26,629 | $1.3M | 0.39% |
| 55 | Roivant Sciences Ltd | ROIV | 100,000 | $1.2M | 0.35% |
| 56 | Alkermes Plc | ALKS | 41,455 | $1.2M | 0.35% |
| 57 | Sarepta Therapeutics Inc | SRPT | 9,197 | $1.1M | 0.34% |
| 58 | Mersana Therapeutics Inc | 59045L106 | 801,600 | $1.0M | 0.31% |
| 59 | Annexon Inc | ANNX | 399,716 | $943,330 | 0.29% |
| 60 | 89bio Inc | 282559103 | 60,247 | $930,214 | 0.28% |
| 61 | BioMarin Pharmaceutical Inc | BMRN | 10,000 | $884,800 | 0.27% |
| 62 | Sagimet Biosciences Inc | SGMT | 100,000 | $880,000 | 0.27% |
| 63 | Schrodinger Inc | SDGR | 30,311 | $856,892 | 0.26% |
| 64 | Voyager Therapeutics Inc | VYGR | 103,966 | $805,737 | 0.24% |
| 65 | Karyopharm Therapeutics Inc | KPTI | 561,955 | $753,020 | 0.23% |
| 66 | Viridian Therapeutics Inc | VRDN | 47,438 | $727,699 | 0.22% |
| 67 | Point Biopharma Global Inc | 730541109 | 93,700 | $624,979 | 0.19% |
| 68 | Rezolute Inc | RZLT | 433,240 | $571,877 | 0.17% |
| 69 | Aligos Therapeutics Inc | ALGS | 631,887 | $472,020 | 0.14% |
| 70 | Compugen Ltd | CGEN | 350,188 | $325,675 | 0.10% |
| 71 | Eliem Therapeutics Inc | CLYM | 121,110 | $318,519 | 0.10% |
| 72 | Relmada Therapeutics Inc | RLMD | 100,000 | $300,000 | 0.09% |
| 73 | Syndax Pharmaceuticals Inc | SNDX | 20,000 | $290,400 | 0.09% |
| 74 | Eloxx Pharmaceuticals Inc | ELOX | 54,075 | $260,101 | 0.08% |
| 75 | Biohaven Ltd | BHVN | 10,000 | $260,100 | 0.08% |
| 76 | Clene Inc | CLNN | 500,000 | $247,950 | 0.08% |
| 77 | Acelyrin Inc | 00445A100 | 23,000 | $233,910 | 0.07% |
| 78 | Scholar Rock Holding Corp | SRRK | 9,711 | $68,948 | 0.02% |
| 79 | Rocket Pharmaceuticals Inc Wts | RCKTW | 104,828 | $17,821 | 0.01% |
| 80 | Aclaris Therapeutics Inc | ACRS | 2,400 | $16,440 | 0.00% |